Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone.

Neurotoxicity research

Morikawa Y, Miyazono H, Kamase K, Suenami K, Sasajima Y, Sato K, Endo S, Monguchi Y, Takekoshi Y, Ikari A, Matsunaga T.
PMID: 34043181
Neurotox Res. 2021 Aug;39(4):1360-1371. doi: 10.1007/s12640-021-00380-8. Epub 2021 May 27.

Chronic exposure to cathinone derivatives increases the risk of severe health hazards, whereas little is known about the detailed pathogenic mechanisms triggered by the derivatives. We have recently shown that treatment with α-pyrrolidinononanophenone (α-PNP, a highly lipophilic cathinone derivative...

Cite
Morikawa Y, Miyazono H, Kamase K, et al. Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone. Neurotox Res. 2021;39(4):1360-1371doi: 10.1007/s12640-021-00380-8.
Morikawa, Y., Miyazono, H., Kamase, K., Suenami, K., Sasajima, Y., Sato, K., Endo, S., Monguchi, Y., Takekoshi, Y., Ikari, A., & Matsunaga, T. (2021). Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone. Neurotoxicity research, 39(4), 1360-1371. https://doi.org/10.1007/s12640-021-00380-8
Morikawa, Yoshifumi, et al. "Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone." Neurotoxicity research vol. 39,4 (2021): 1360-1371. doi: https://doi.org/10.1007/s12640-021-00380-8
Morikawa Y, Miyazono H, Kamase K, Suenami K, Sasajima Y, Sato K, Endo S, Monguchi Y, Takekoshi Y, Ikari A, Matsunaga T. Protective Effect of Aldo-keto Reductase 1B1 Against Neuronal Cell Damage Elicited by 4'-Fluoro-α-pyrrolidinononanophenone. Neurotox Res. 2021 Aug;39(4):1360-1371. doi: 10.1007/s12640-021-00380-8. Epub 2021 May 27. PMID: 34043181.
Copy Download .nbib Format: NLM
Diabetes-induced auditory complications: are they preventable? a comprehensive review of interventions.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Hajiabolhassan F, Tavanai E.
PMID: 33555440
Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3653-3665. doi: 10.1007/s00405-021-06630-x. Epub 2021 Feb 08.

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels, which, over time, lead to major chronic complications in various organs of the body. A growing body of research suggests that diabetes could also result in...

Cite
Hajiabolhassan F, Tavanai E. Diabetes-induced auditory complications: are they preventable? a comprehensive review of interventions. Eur Arch Otorhinolaryngol. 2021;278(10):3653-3665doi: 10.1007/s00405-021-06630-x.
Hajiabolhassan, F., & Tavanai, E. (2021). Diabetes-induced auditory complications: are they preventable? a comprehensive review of interventions. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 278(10), 3653-3665. https://doi.org/10.1007/s00405-021-06630-x
Hajiabolhassan, Fahimeh, and Tavanai, Elham. "Diabetes-induced auditory complications: are they preventable? a comprehensive review of interventions." European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery vol. 278,10 (2021): 3653-3665. doi: https://doi.org/10.1007/s00405-021-06630-x
Hajiabolhassan F, Tavanai E. Diabetes-induced auditory complications: are they preventable? a comprehensive review of interventions. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3653-3665. doi: 10.1007/s00405-021-06630-x. Epub 2021 Feb 08. PMID: 33555440.
Copy Download .nbib Format: NLM
Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy.

Clinical drug investigation

Didangelos TP, Athyros VG, Karamitsos DT, Papageorgiou AA, Kourtoglou GI, Kontopoulos AG.
PMID: 18370475
Clin Drug Investig. 1998;15(2):111-21. doi: 10.2165/00044011-199815020-00005.

Patients with diabetic autonomic neuropathy (DAN) have an increased cardiovascular mortality rate compared with diabetic patients without DAN. Heart rate variability (HRV) time and frequency domain indices are strong predictors of malignant arrhythmias and sudden cardiac death. This prospective,...

Cite
Didangelos TP, Athyros VG, Karamitsos DT, et al. Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy. Clin Drug Investig. 1998;15(2):111-21doi: 10.2165/00044011-199815020-00005.
Didangelos, T. P., Athyros, V. G., Karamitsos, D. T., Papageorgiou, A. A., Kourtoglou, G. I., & Kontopoulos, A. G. (1998). Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy. Clinical drug investigation, 15(2), 111-21. https://doi.org/10.2165/00044011-199815020-00005
Didangelos, T P, et al. "Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy." Clinical drug investigation vol. 15,2 (1998): 111-21. doi: https://doi.org/10.2165/00044011-199815020-00005
Didangelos TP, Athyros VG, Karamitsos DT, Papageorgiou AA, Kourtoglou GI, Kontopoulos AG. Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy. Clin Drug Investig. 1998;15(2):111-21. doi: 10.2165/00044011-199815020-00005. PMID: 18370475.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries